Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluating the Effect of Curcumin in Preventing Paclitaxel-Induced Peripheral Neuropathy in Breast Cancer Patients

NCT05966441 is registered in ClinicalTrials.gov with Ain Shams University as lead sponsor.

NCT NCT05966441
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05966441 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluating the Effect of Curcumin in Preventing Paclitaxel-Induced Peripheral Neuropathy in Breast Cancer Patients
Lead sponsor
Ain Shams University
Phase
Phase 2
Overall status
Unknown status
Start date
August 30, 2023
Completion date
March 10, 2024
Enrollment
80 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

chemotherapy-induced peripheral neuropathy